Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Alan

Showing results (331-340 of 382) with videos related to

Pageof 39
Sort By:
Pediatrics|November 5, 2021
Secondary Transmission of COVID-19 in K-12 Schools: Findings From 2 StatesAngelique E Boutzoukas, Kanecia O Zimmerman, Daniel K Benjamin, et al.
Epidemiology (Cambridge, Mass.)|January 31, 2023
Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial EmulationAlexander Breskin, Catherine Wiener, Adaora A Adimora, et al.
Journal of the American Academy of Dermatology|October 3, 2006
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension studyKenneth B Gordon, Richard G Langley, Craig Leonardi, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 29, 2024
Pioglitazone does not enhance exogenous glucose oxidation or metabolic clearance rate during aerobic exercise in men under acute high-altitude exposureLee M Margolis, Marques A Wilson, Devin J Drummer, et al.
Journal of General Internal Medicine|February 28, 2009
Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the Target pharmacy labelWilliam H Shrank, Patrick P Gleason, Claire Canning, et al.
Human Molecular Genetics|February 29, 2008
Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterolLatisha Love-Gregory, Richard Sherva, Lingwei Sun, et al.
Health Affairs (Project Hope)|November 3, 2010
At Pitney Bowes, value-based insurance design cut copayments and increased drug adherenceNiteesh K Choudhry, Michael A Fischer, Jerry Avorn, et al.
Pharmacoepidemiology and Drug Safety|November 27, 2015
Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confoundersDavid T Gilbertson, Brian D Bradbury, James B Wetmore, et al.
Pharmacoepidemiology and Drug Safety|March 25, 2023
Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative reviewSara N Levintow, Carrie M Nielson, Rohini K Hernandez, et al.
Journal of the American Academy of Dermatology|May 8, 2003
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeksGerald D Weinstein, John Y M Koo, Gerald G Krueger, et al.
Pageof 39

Showing results (331-340 of 382) with videos related to

Sort By:
Pageof 39
Pediatrics|November 5, 2021
Secondary Transmission of COVID-19 in K-12 Schools: Findings From 2 StatesAngelique E Boutzoukas, Kanecia O Zimmerman, Daniel K Benjamin, et al.
Epidemiology (Cambridge, Mass.)|January 31, 2023
Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial EmulationAlexander Breskin, Catherine Wiener, Adaora A Adimora, et al.
Journal of the American Academy of Dermatology|October 3, 2006
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension studyKenneth B Gordon, Richard G Langley, Craig Leonardi, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 29, 2024
Pioglitazone does not enhance exogenous glucose oxidation or metabolic clearance rate during aerobic exercise in men under acute high-altitude exposureLee M Margolis, Marques A Wilson, Devin J Drummer, et al.
Journal of General Internal Medicine|February 28, 2009
Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the Target pharmacy labelWilliam H Shrank, Patrick P Gleason, Claire Canning, et al.
Human Molecular Genetics|February 29, 2008
Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterolLatisha Love-Gregory, Richard Sherva, Lingwei Sun, et al.
Health Affairs (Project Hope)|November 3, 2010
At Pitney Bowes, value-based insurance design cut copayments and increased drug adherenceNiteesh K Choudhry, Michael A Fischer, Jerry Avorn, et al.
Pharmacoepidemiology and Drug Safety|November 27, 2015
Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confoundersDavid T Gilbertson, Brian D Bradbury, James B Wetmore, et al.
Pharmacoepidemiology and Drug Safety|March 25, 2023
Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative reviewSara N Levintow, Carrie M Nielson, Rohini K Hernandez, et al.
Journal of the American Academy of Dermatology|May 8, 2003
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeksGerald D Weinstein, John Y M Koo, Gerald G Krueger, et al.
Pageof 39